TEMLOVA
DEAD

Serial Number

86544741

Owner

FURIEX PHARMACEUTICALS, LLC

Attorney

Matthew O. Brady

Filing Date

Feb 24, 2015

Add to watchlist:

No watchlists yet
View on USPTO

TEMLOVA Trademark

Serial Number: 86544741

TEMLOVA is a trademark filed by FURIEX PHARMACEUTICALS, LLC on February 24, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

FURIEX PHARMACEUTICALS, LLC (14 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 16

FURIEX PHARMACEUTICALS, INC. (9 trademarks)

3900 PARAMOUNT PARKWAY, SUITE 150
MORRISVILLE, NC 27560

Entity Type: 03

Trademark Details

Filing Date

February 24, 2015

Registration Date

Not Registered

Published for Opposition

June 16, 2015

Goods & Services

Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics, Antifungals, Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 14, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 14, 2016 ABN6
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 9, 2016 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 11, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 8, 2015 PREV
ASSIGNED TO LIE
May 6, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2015 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2015 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2015 NWOS
NEW APPLICATION ENTERED
Feb 27, 2015 NWAP